187 related articles for article (PubMed ID: 22457594)
1. Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.
Vega E; Egea MA; Calpena AC; Espina M; García ML
Int J Nanomedicine; 2012; 7():1357-71. PubMed ID: 22457594
[TBL] [Abstract][Full Text] [Related]
2. Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy.
Vega E; Egea MA; Garduño-Ramírez ML; García ML; Sánchez E; Espina M; Calpena AC
Colloids Surf B Biointerfaces; 2013 Oct; 110():339-46. PubMed ID: 23743255
[TBL] [Abstract][Full Text] [Related]
3. Influence of freeze-drying and γ-irradiation in preclinical studies of flurbiprofen polymeric nanoparticles for ocular delivery using d-(+)-trehalose and polyethylene glycol.
Ramos Yacasi GR; García López ML; Espina García M; Parra Coca A; Calpena Campmany AC
Int J Nanomedicine; 2016; 11():4093-106. PubMed ID: 27601897
[TBL] [Abstract][Full Text] [Related]
4. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
Bozdag S; Dillen K; Vandervoort J; Ludwig A
J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
[TBL] [Abstract][Full Text] [Related]
5. Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders.
Silva-Abreu M; Calpena AC; Espina M; Silva AM; Gimeno A; Egea MA; García ML
Pharm Res; 2018 Jan; 35(1):11. PubMed ID: 29299768
[TBL] [Abstract][Full Text] [Related]
6. PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.
Vega E; Gamisans F; García ML; Chauvet A; Lacoulonche F; Egea MA
J Pharm Sci; 2008 Dec; 97(12):5306-17. PubMed ID: 18425815
[TBL] [Abstract][Full Text] [Related]
7. PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).
Gupta V; Davis M; Hope-Weeks LJ; Ahsan F
Pharm Res; 2011 Jul; 28(7):1733-49. PubMed ID: 21626061
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.
Koushik K; Dhanda DS; Cheruvu NP; Kompella UB
Pharm Res; 2004 Jul; 21(7):1119-26. PubMed ID: 15290850
[TBL] [Abstract][Full Text] [Related]
9. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
Desai KG; Mallery SR; Schwendeman SP
Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
[TBL] [Abstract][Full Text] [Related]
10. PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization.
Sánchez-López E; Egea MA; Cano A; Espina M; Calpena AC; Ettcheto M; Camins A; Souto EB; Silva AM; García ML
Colloids Surf B Biointerfaces; 2016 Sep; 145():241-250. PubMed ID: 27187188
[TBL] [Abstract][Full Text] [Related]
11. Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability.
Ramos Yacasi GR; Calpena Campmany AC; Egea Gras MA; Espina García M; García López ML
Drug Dev Ind Pharm; 2017 Apr; 43(4):637-651. PubMed ID: 28044462
[TBL] [Abstract][Full Text] [Related]
12. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers.
Stolnik S; Dunn SE; Garnett MC; Davies MC; Coombes AG; Taylor DC; Irving MP; Purkiss SC; Tadros TF; Davis SS
Pharm Res; 1994 Dec; 11(12):1800-8. PubMed ID: 7899246
[TBL] [Abstract][Full Text] [Related]
13. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres.
Araújo J; Vega E; Lopes C; Egea MA; Garcia ML; Souto EB
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):48-56. PubMed ID: 19403277
[TBL] [Abstract][Full Text] [Related]
14. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
15. Formulation, characterization and evaluation of cyclodextrin-complexed bendamustine-encapsulated PLGA nanospheres for sustained delivery in cancer treatment.
Gidwani B; Vyas A
Pharm Dev Technol; 2016 Mar; 21(2):161-71. PubMed ID: 25391288
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
[TBL] [Abstract][Full Text] [Related]
17. How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system.
De Rosa G; Larobina D; Immacolata La Rotonda M; Musto P; Quaglia F; Ungaro F
J Control Release; 2005 Jan; 102(1):71-83. PubMed ID: 15653135
[TBL] [Abstract][Full Text] [Related]
18. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits.
Musumeci T; Bucolo C; Carbone C; Pignatello R; Drago F; Puglisi G
Int J Pharm; 2013 Jan; 440(2):135-40. PubMed ID: 23078856
[TBL] [Abstract][Full Text] [Related]
19. Effect of stabilizers on bioactivity of peptide-24 in PLGA microspheres.
Wang M; Guo X; Tan R; She Z; Feng Q
Med Chem; 2013 Dec; 9(8):1123-8. PubMed ID: 23227911
[TBL] [Abstract][Full Text] [Related]
20. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T
J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
